Multimodal neuroimaging of Parkinson’s disease with diffusion tensor imaging (DTI) and dopamine transporter (DAT) positron emission tomography
Objective: The main aims of this study were to characterize brain microstructure alterations in a cross-sectional cohort of Parkinson’s disease (PD) with DTI and assess…Early-phase 18F-FP-CIT PET images: a promising imaging biomarker for predicting early dementia conversion in Parkinson’s disease
Objective: This study aims to investigate whether early-phase 18F-N-(3-fluoropropyl)-2β-carboxymethoxy-3β-(4-iodophenyl) nortropane (18F-FP-CIT) positron emission tomography (PET) images (i.e., images acquired within the first 10 min after…The pivotal role of dual tracer (FDG + DOPA) PET MRI brain for diagnosis of MSA-C.
Objective: This case report demonstrates the potential of dual-tracer imaging (FDG + DOPA) PET MRI brain in diagnosing and distinguishing the patients with MSA-C from atypical…MRI morphometry and regional hypometabolism in the clinical predominance-types of Progressive Supranuclear Palsy
Objective: To compare brain MRI morphometry and regional hypometabolism among the clinical predominance-types of Progressive Supranuclear Palsy. Background: Recently, MDS-PSP criteria for the clinical diagnosis…Asymmetric synaptic density and glucose consumption in subjects with non-demented Parkinson’s Disease, as measured with [11C]UCB-J and [18F]FDG PET.
Objective: The objective of this study was to investigate asymmetric synaptic density and glucose consumption in moderate-stage non demented PD patients and the association between…Association of Increased Frontal White Matter A2A Receptor Availability with Decreased Frontal Gray Matter Volume in Patients with Parkinson’s Disease
Objective: We sought to investigate in vivo changes in A2A receptor availability in cerebral white matter of PD patients and its association with gray matter…Study protocol for the iMarkHD study in individuals with Huntington’s disease
Objective: To describe the study protocol for the iMarkHD study. Background: Huntington’s disease (HD) is still often defined by the onset of motor symptoms, inversely…Functional network correlates of APOE ε4 allele in Parkinson’s disease
Objective: To investigate the influence of APOE ε4 allele on metabolic network activity and functional connectivity in patients with Parkinson's disease (PD). Background: Disease progression…Neurofilament light chain, tau-PET and microglia-PET predict clinical progression in amyloid-negative corticobasal syndrome
Objective: A head-to-head comparison of neuroimaging (tau-PET, microglia-PET, structural MRI) and plasma biomarker Neurofilament light chain (NfL) as prognostic tools for longitudinal clinical trajectories in…Tau PET imaging in a patient with progressive supranuclear palsy-parkinsonism-a case report
Objective: Early detection of the brain tau deposition in patients with progressive supranuclear palsy-parkinsonism (PSP-P) by 18F-PMPBB3 positron emission tomography (PET) imaging. Background: PSP is…
- « Previous Page
- 1
- …
- 6
- 7
- 8
- 9
- 10
- …
- 33
- Next Page »